K11AI001163 (SHIRAMIZU, BRUCE T.)Aug 1, 1994 - Nov 30, 1997 NIH/NIAID INTEGRATED HIV AND AIDS T CELL LYMPHOMAS Role: Principal Investigator |
|
R21MH069173 (SHIRAMIZU, BRUCE T.)Jul 1, 2003 - Jun 30, 2006 NIH/NIMH Activated Immune Parameters Associated with HIV &Aging Role: Principal Investigator |
|
R01NS053345 (SHIRAMIZU, BRUCE T.)May 1, 2006 - Apr 30, 2013 NIH/NINDS HIV-1 Proviral DNA and Monocyte Phenotype in Relation to Neurocognitive Function Role: Principal Investigator |
|
R21CA121955 (SHIRAMIZU, BRUCE T.)Jul 10, 2006 - Jun 30, 2008 NIH/NCI Real-time Minimal Residual Disease assay of Pediatric B-Cell Non-Hodgkin Lymphoma Role: Principal Investigator |
|
R21CA139712 (ERNST, THOMAS M)Jun 20, 2009 - May 31, 2013 NIH/NCI Neuroimaging to Assess the Effects of Therapy in Children with Acute Lymphoblasti Role: Co-Principal Investigator |
|
U54MD007584 (SHIRAMIZU, BRUCE T.)Sep 16, 2010 - Jun 30, 2014 NIH/NIMHD RCMI Multidisciplinary And Translational Research Infrastructure EXpansion (RAMAT Role: Principal Investigator |
|
R01MH102196 (SHIRAMIZU, BRUCE T.)Aug 15, 2014 - May 31, 2019 NIH/NIMH Maraviroc and NeuroAIDS Pathogenesis Role: Principal Investigator |
|
UG1HD090879 (SHIRAMIZU, BRUCE T.)Sep 21, 2016 - Aug 31, 2020 NIH/NICHD Hawaii IDeA Center for Pediatric and Adolescent Clinical Trials (HIPACT) Role: Principal Investigator |
|
UG1OD024948 (SHIRAMIZU, BRUCE T.)Sep 21, 2016 - Aug 31, 2020 NIH Hawaii IDeA Center for Pediatric and Adolescent Clinical Trials (HIPACT) Role: Principal Investigator |
|
R21CA216830 (SHIRAMIZU, BRUCE T.)Jun 1, 2017 - May 31, 2019 NIH/NCI (PQ5) Informing anal neoplasia differences/similarities in HIV-serodiscordant individuals Role: Principal Investigator |
|
R21CA244078 (SHIRAMIZU, BRUCE T)Aug 1, 2020 - Jul 31, 2022 NIH/NCI Raman-enhanced spectroscopy (RESpect) for anal dysplasia in HIV-positive patients Role: Principal Investigator |